Taegyu Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Taegyu Kang has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Homan Kang
Center for Inflammation Imaging, Department of Radiology, Massachusetts General Brigham and Harvard Medical School, Boston, MA 02115, USA
6 shared publications - Bong-Hyun Jun
Department of Bioscience and Biotechnology Konkuk University Seoul Republic of Korea
4 shared publications - Dae Hong Jeong
Department of Chemistry Education, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 08826, Republic of Korea
4 shared publications - Taeghwan Hyeon
Center for Nanoparticle Research, Institute for Basic Science, Seoul, Republic of Korea
4 shared publications - Yoon-Sik Lee
School of Chemical and Biological Engineering, Seoul National University, Seoul 08826, Republic of Korea
4 shared publications Bong-Hyun Jun
School of Chemical and Biological Engineering, Seoul National University, Seoul, 151‐747, Korea
3 shared publications
Latest Publications
- 5 September 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (8) , e2401994
Orally Deliverable Iron‐Ceria Nanotablets for Treatment of Inflammatory Bowel Disease
Ceria‐based nanoparticles are versatile in treating various inflammatory diseases, but their feasibility in clinical translation is undermined by safety concerns and a limited delivery system. Meanwhile, the idiopathic nature of inflammatory bowel disease (IBD) calls for a wider variety of therapeutics via moderation of the intestinal immune system. In this regard, the synthesis and oral formulation of iron‐ceria nanoparticles (CF NPs) with enhanced nanozymic activity and lower toxicity risk than conventional ceria‐based nanoparticles are reported. CF NPs are clustered in calcium phosphate (CaP) and coated with a pH‐responsive polymer to provide the enteric formulation of iron‐ceria nanotablets (CFNT). CFNT exhibits a marked alleviative efficacy in the dextran sodium sulfate (DSS)‐induced enterocolitis model in vivo by modulating the pro‐inflammatory behavior of innate immune cells including macrophages and neutrophils, promoting anti‐inflammatory cytokine profiles, and downregulating key transcription factors of inflammatory pathways.
- 5 September 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (8) , e2401994
Orally Deliverable Iron‐Ceria Nanotablets for Treatment of Inflammatory Bowel Disease
Ceria‐based nanoparticles are versatile in treating various inflammatory diseases, but their feasibility in clinical translation is undermined by safety concerns and a limited delivery system. Meanwhile, the idiopathic nature of inflammatory bowel disease (IBD) calls for a wider variety of therapeutics via moderation of the intestinal immune system. In this regard, the synthesis and oral formulation of iron‐ceria nanoparticles (CF NPs) with enhanced nanozymic activity and lower toxicity risk than conventional ceria‐based nanoparticles are reported. CF NPs are clustered in calcium phosphate (CaP) and coated with a pH‐responsive polymer to provide the enteric formulation of iron‐ceria nanotablets (CFNT). CFNT exhibits a marked alleviative efficacy in the dextran sodium sulfate (DSS)‐induced enterocolitis model in vivo by modulating the pro‐inflammatory behavior of innate immune cells including macrophages and neutrophils, promoting anti‐inflammatory cytokine profiles, and downregulating key transcription factors of inflammatory pathways.
- Top Cited Papers
- 16 March 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (6) , 5435-5447
Penetrative and Sustained Drug Delivery Using Injectable Hydrogel Nanocomposites for Postsurgical Brain Tumor Treatment
Postsurgical treatment of glioblastoma multiforme (GBM) by systemic chemotherapy and radiotherapy is often inefficient. Tumor cells infiltrating deeply into the brain parenchyma are significant obstacles to the eradication of GBM. Here, we present a potential solution to this challenge by introducing an injectable thermoresponsive hydrogel nanocomposite. As a liquid solution that contains drug-loaded micelles and water-dispersible ferrimagnetic iron oxide nanocubes (wFIONs), the hydrogel nanocomposite is injected into the resected tumor site after surgery. It promptly gelates at body temperature to serve as a soft, deep intracortical drug reservoir. The drug-loaded micelles target residual GBM cells and deliver drugs with a minimum premature release. Alternating magnetic fields accelerate diffusion through heat generation from wFIONs, enabling penetrative drug delivery. Significantly suppressed tumor growth and improved survival rates are demonstrated in an orthotopic mouse GBM model. Our system proves the potential of the hydrogel nanocomposite platform for postsurgical GBM treatment.
- 16 March 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (6) , 5435-5447
Top Cited PapersPenetrative and Sustained Drug Delivery Using Injectable Hydrogel Nanocomposites for Postsurgical Brain Tumor Treatment
Postsurgical treatment of glioblastoma multiforme (GBM) by systemic chemotherapy and radiotherapy is often inefficient. Tumor cells infiltrating deeply into the brain parenchyma are significant obstacles to the eradication of GBM. Here, we present a potential solution to this challenge by introducing an injectable thermoresponsive hydrogel nanocomposite. As a liquid solution that contains drug-loaded micelles and water-dispersible ferrimagnetic iron oxide nanocubes (wFIONs), the hydrogel nanocomposite is injected into the resected tumor site after surgery. It promptly gelates at body temperature to serve as a soft, deep intracortical drug reservoir. The drug-loaded micelles target residual GBM cells and deliver drugs with a minimum premature release. Alternating magnetic fields accelerate diffusion through heat generation from wFIONs, enabling penetrative drug delivery. Significantly suppressed tumor growth and improved survival rates are demonstrated in an orthotopic mouse GBM model. Our system proves the potential of the hydrogel nanocomposite platform for postsurgical GBM treatment.
- 6 May 2021
- Published by Wiley in Advanced Materials
- Vol. 33 (24) , 2100425
Localized Delivery of Theranostic Nanoparticles and High‐Energy Photons using Microneedles‐on‐Bioelectronics
The low delivery efficiency of light‐responsive theranostic nanoparticles (NPs) to target tumor sites, particularly to brain tumors due to the blood–brain barrier, has been a critical issue in NP‐based cancer treatments. Furthermore, high‐energy photons that can effectively activate theranostic NPs are hardly delivered to the target region due to the strong scattering of such photons while penetrating surrounding tissues. Here, a localized delivery method of theranostic NPs and high‐energy photons to the target tumor using microneedles‐on‐bioelectronics is presented. Two types of microneedles and flexible bioelectronics are integrated and mounted on the edge of surgical forceps. Bioresorbable microneedles containing theranostic NPs deliver the NPs into target tumors (e.g., glioblastoma, pituitary adenoma). Magnetic resonance imaging can locate the NPs. Then, light‐guiding/spreading microneedles deliver high‐energy photons from bioelectronics to the NPs. The high‐energy photons activate the NPs to treat tumor tissues by photodynamic therapy and chemotherapy. The controlled thermal actuation by the bioelectronics accelerates the diffusion of chemo‐drugs. The proposed method is demonstrated with mouse tumor models in vivo.
- 6 May 2021
- Published by Wiley in Advanced Materials
- Vol. 33 (24) , 2100425
Localized Delivery of Theranostic Nanoparticles and High‐Energy Photons using Microneedles‐on‐Bioelectronics
The low delivery efficiency of light‐responsive theranostic nanoparticles (NPs) to target tumor sites, particularly to brain tumors due to the blood–brain barrier, has been a critical issue in NP‐based cancer treatments. Furthermore, high‐energy photons that can effectively activate theranostic NPs are hardly delivered to the target region due to the strong scattering of such photons while penetrating surrounding tissues. Here, a localized delivery method of theranostic NPs and high‐energy photons to the target tumor using microneedles‐on‐bioelectronics is presented. Two types of microneedles and flexible bioelectronics are integrated and mounted on the edge of surgical forceps. Bioresorbable microneedles containing theranostic NPs deliver the NPs into target tumors (e.g., glioblastoma, pituitary adenoma). Magnetic resonance imaging can locate the NPs. Then, light‐guiding/spreading microneedles deliver high‐energy photons from bioelectronics to the NPs. The high‐energy photons activate the NPs to treat tumor tissues by photodynamic therapy and chemotherapy. The controlled thermal actuation by the bioelectronics accelerates the diffusion of chemo‐drugs. The proposed method is demonstrated with mouse tumor models in vivo.
- Top Cited PapersOpen Access
- 15 November 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 5205
Flexible, sticky, and biodegradable wireless device for drug delivery to brain tumors
Implantation of biodegradable wafers near the brain surgery site to deliver anti-cancer agents which target residual tumor cells by bypassing the blood-brain barrier has been a promising method for brain tumor treatment. However, further improvement in the prognosis is still necessary. We herein present novel materials and device technologies for drug delivery to brain tumors, i.e., a flexible, sticky, and biodegradable drug-loaded patch integrated with wireless electronics for controlled intracranial drug delivery through mild-thermic actuation. The flexible and bifacially-designed sticky/hydrophobic device allows conformal adhesion on the brain surgery site and provides spatially-controlled and temporarily-extended drug delivery to brain tumors while minimizing unintended drug leakage to the cerebrospinal fluid. Biodegradation of the entire device minimizes potential neurological side-effects. Application of the device to the mouse model confirms tumor volume suppression and improved survival rate. Demonstration in a large animal model (canine model) exhibited its potential for human application.
- 15 November 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 5205
Top Cited PapersOpen AccessFlexible, sticky, and biodegradable wireless device for drug delivery to brain tumors
Implantation of biodegradable wafers near the brain surgery site to deliver anti-cancer agents which target residual tumor cells by bypassing the blood-brain barrier has been a promising method for brain tumor treatment. However, further improvement in the prognosis is still necessary. We herein present novel materials and device technologies for drug delivery to brain tumors, i.e., a flexible, sticky, and biodegradable drug-loaded patch integrated with wireless electronics for controlled intracranial drug delivery through mild-thermic actuation. The flexible and bifacially-designed sticky/hydrophobic device allows conformal adhesion on the brain surgery site and provides spatially-controlled and temporarily-extended drug delivery to brain tumors while minimizing unintended drug leakage to the cerebrospinal fluid. Biodegradation of the entire device minimizes potential neurological side-effects. Application of the device to the mouse model confirms tumor volume suppression and improved survival rate. Demonstration in a large animal model (canine model) exhibited its potential for human application.
- 1 December 2015
- Published by Elsevier in Journal of Industrial and Engineering Chemistry
- Vol. 32, 34-38
Fabrication of Ag nanoaggregates/SiO2 yolk–shell nanoprobes for surface-enhanced Raman scattering
- 1 December 2015
- Published by Elsevier in Journal of Industrial and Engineering Chemistry
- Vol. 32, 34-38
Fabrication of Ag nanoaggregates/SiO2 yolk–shell nanoprobes for surface-enhanced Raman scattering
- Open Access
- 2 May 2012
- Published by Wiley in Advanced Functional Materials
- Vol. 22 (9) , 1774
Quantum Dots: Ultrasensitive, Biocompatible, Quantum-Dot-Embedded Silica Nanoparticles for Bioimaging (Adv. Funct. Mater. 9/2012)
- 2 May 2012
- Published by Wiley in Advanced Functional Materials
- Vol. 22 (9) , 1774
Open AccessQuantum Dots: Ultrasensitive, Biocompatible, Quantum-Dot-Embedded Silica Nanoparticles for Bioimaging (Adv. Funct. Mater. 9/2012)
- 17 February 2012
- Published by Wiley in Advanced Functional Materials
- Vol. 22 (9) , 1843-1849
Ultrasensitive, Biocompatible, Quantum‐Dot‐Embedded Silica Nanoparticles for Bioimaging
The successful development of highly sensitive, water‐compatible, nontoxic nanoprobes has allowed nanomaterials to be widely employed in various applications. The applicability of highly bright quantum dot (QD)‐based probes consisting of QDs on 120 nm silica nanoparticles (NPs) with silica shells is investigated. Their substantial merits, such as their brightness and biocompatibility, for effective bioimaging are demonstrated. Silica‐coated, QD‐embedded silica NPs (Si@QDs@Si NPs) containing QDs composed of CdSe@ZnS (core‐shell) are prepared to compare their structure‐based advantages over single QDs that have a similar quantum yield (QY). These Si@QDs@Si NPs exhibit approximately 200‐times stronger photoluminescence (PL) than single QDs. Cytotoxicity studies reveal that the Si@QDs@Si NPs are less toxic than equivalent numbers of silica‐free single quantum dots. The excellence of the Si@QDs@Si NPs with regard to in vivo applications is illustrated by significantly enhanced fluorescence signals from Si@QDs@Si‐NP‐tagged cells implanted in mice. Notably, a more advanced version of QD‐based silica NPs (Si@mQDs@Si NPs), containing multishell quantum dots (mQDs) composed of CdSe@CdS@ZnS, are prepared without significant loss of QY during surface modification. In addition, the Si@mQDs@Si NPs display a fivefold higher fluorescence activity than the Si@QDs@Si NPs. As few as 400 units of Si@mQDs@Si‐ NP‐internalized cells can be detected in the cell‐implanted mouse model.
- 17 February 2012
- Published by Wiley in Advanced Functional Materials
- Vol. 22 (9) , 1843-1849
Ultrasensitive, Biocompatible, Quantum‐Dot‐Embedded Silica Nanoparticles for Bioimaging
The successful development of highly sensitive, water‐compatible, nontoxic nanoprobes has allowed nanomaterials to be widely employed in various applications. The applicability of highly bright quantum dot (QD)‐based probes consisting of QDs on 120 nm silica nanoparticles (NPs) with silica shells is investigated. Their substantial merits, such as their brightness and biocompatibility, for effective bioimaging are demonstrated. Silica‐coated, QD‐embedded silica NPs (Si@QDs@Si NPs) containing QDs composed of CdSe@ZnS (core‐shell) are prepared to compare their structure‐based advantages over single QDs that have a similar quantum yield (QY). These Si@QDs@Si NPs exhibit approximately 200‐times stronger photoluminescence (PL) than single QDs. Cytotoxicity studies reveal that the Si@QDs@Si NPs are less toxic than equivalent numbers of silica‐free single quantum dots. The excellence of the Si@QDs@Si NPs with regard to in vivo applications is illustrated by significantly enhanced fluorescence signals from Si@QDs@Si‐NP‐tagged cells implanted in mice. Notably, a more advanced version of QD‐based silica NPs (Si@mQDs@Si NPs), containing multishell quantum dots (mQDs) composed of CdSe@CdS@ZnS, are prepared without significant loss of QY during surface modification. In addition, the Si@mQDs@Si NPs display a fivefold higher fluorescence activity than the Si@QDs@Si NPs. As few as 400 units of Si@mQDs@Si‐ NP‐internalized cells can be detected in the cell‐implanted mouse model.
- 1 July 2011
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 11 (7) , 6249-6252
Immobilization of Aptamer-Based Molecular Beacons Onto Optically-Encoded Micro-Sized Beads
This paper presents a method for the novel immobilization of aptamer-based molecular beacons (apta-beacons) onto optically-encoded micro-sized beads (apta-beacon beads). To immobilize aptabeacons onto flourescently-encoded micro-sized beads, core–shell type beads containing a fluorescent dye-encoded core and apta beacon-coupled shell were prepared. The fluorescent dye-encoded beads were prepared from TentaGel resins by coupling RITC to the amino groups of the core region, after partial protection of amino groups with Fmoc-OSu in a diffusion-controlled manner. After deprotection of the Fmoc-amino groups, FITC-coupled molecular beacons (MBs) were immobilized to the beads together with a quencher by covelent bonding. Briefly, aspartic acid (Asp) was coupled to the shell part of the beads. Then, the quencher was coupled to the N-terminal amino group of Asp and the MBs were coupled to the side chain carboxyl group. In a model study, thrombin was directly detected using this apta-beacon bead method. The thrombin-bound apta-beacon beads were easily recognized by the appearance of fluorescence without any further labeling step.
- 1 July 2011
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 11 (7) , 6249-6252
Immobilization of Aptamer-Based Molecular Beacons Onto Optically-Encoded Micro-Sized Beads
This paper presents a method for the novel immobilization of aptamer-based molecular beacons (apta-beacons) onto optically-encoded micro-sized beads (apta-beacon beads). To immobilize aptabeacons onto flourescently-encoded micro-sized beads, core–shell type beads containing a fluorescent dye-encoded core and apta beacon-coupled shell were prepared. The fluorescent dye-encoded beads were prepared from TentaGel resins by coupling RITC to the amino groups of the core region, after partial protection of amino groups with Fmoc-OSu in a diffusion-controlled manner. After deprotection of the Fmoc-amino groups, FITC-coupled molecular beacons (MBs) were immobilized to the beads together with a quencher by covelent bonding. Briefly, aspartic acid (Asp) was coupled to the shell part of the beads. Then, the quencher was coupled to the N-terminal amino group of Asp and the MBs were coupled to the side chain carboxyl group. In a model study, thrombin was directly detected using this apta-beacon bead method. The thrombin-bound apta-beacon beads were easily recognized by the appearance of fluorescence without any further labeling step.
- 1 January 2011
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 11 (1) , 579-583
Base Effects on Fabrication of Silver Nanoparticles Embedded Silica Nanocomposite for Surface-Enhanced Raman Scattering (SERS)
In this paper, we studied on the effect of organic bases in the case of ethylene glycol based fabrication of silver nanoparticles embedded silica nanocomposite (Ag SNC) without heating. Considering their chemical structures, butylamine (BA), ethanolamine (EA), triethanolamine (TEA), tributylamine (TBA), octylamine (OA) and Jeffamine 500 (JA) were used as an organic base. In addition, the effect of the concentrations of AgNO3 and organic bases on the formation of Ag SNC was also examined. In conformity with the characteristics of Ag SNC, SERS signal intensity of benzenethiol on Ag SNC was measured. As a result, the SERS signal intensity of Ag SNCs was strongly dependent on the reaction conditions. Furthermore, when reacted under the best reaction condition with concentrations of AgNO3 and OA, 3 mM and 5 mM, respectively, a large-scale production of Ag SNC was possible under the mild conditions.
- 1 January 2011
- Published by American Scientific Publishers in Journal of Nanoscience and Nanotechnology
- Vol. 11 (1) , 579-583
Base Effects on Fabrication of Silver Nanoparticles Embedded Silica Nanocomposite for Surface-Enhanced Raman Scattering (SERS)
In this paper, we studied on the effect of organic bases in the case of ethylene glycol based fabrication of silver nanoparticles embedded silica nanocomposite (Ag SNC) without heating. Considering their chemical structures, butylamine (BA), ethanolamine (EA), triethanolamine (TEA), tributylamine (TBA), octylamine (OA) and Jeffamine 500 (JA) were used as an organic base. In addition, the effect of the concentrations of AgNO3 and organic bases on the formation of Ag SNC was also examined. In conformity with the characteristics of Ag SNC, SERS signal intensity of benzenethiol on Ag SNC was measured. As a result, the SERS signal intensity of Ag SNCs was strongly dependent on the reaction conditions. Furthermore, when reacted under the best reaction condition with concentrations of AgNO3 and OA, 3 mM and 5 mM, respectively, a large-scale production of Ag SNC was possible under the mild conditions.
- 10 December 2010
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 47 (8) , 2306-2308
Encoding peptide sequences with surface-enhanced Raman spectroscopic nanoparticles
Peptides synthesized on microbeads were encoded by chemically and physically adsorbing surface-enhanced Raman spectroscopic nanoparticles (SERS dots) on the microbead surface during the synthesis, which could be easily and rapidly decoded by Raman spectroscopy.
- 10 December 2010
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 47 (8) , 2306-2308
Encoding peptide sequences with surface-enhanced Raman spectroscopic nanoparticles
Peptides synthesized on microbeads were encoded by chemically and physically adsorbing surface-enhanced Raman spectroscopic nanoparticles (SERS dots) on the microbead surface during the synthesis, which could be easily and rapidly decoded by Raman spectroscopy.